Novartis Ag NVS
NYSE NVS
$158.86 +2.62 (+1.68%)
At close: Aug 21, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Change in Intangibles (2009 - 2026)

Novartis Ag (NVS) posted Change in Intangibles of -$461.0 million for Q1 2026, down 511.61% sequentially from $112.0 million in Q4 2025.

Novartis Ag (NVS) Change in Intangibles (2009 - 2026) Analysis & Trends

Novartis Ag has reported Change in Intangibles for 14 years, with the latest figure at -$461.0 million in Q1 2026.

  • Quarterly Change in Intangibles changed N/A year-over-year to -$461.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$524.0 million (changed N/A YoY) and the FY2025 annual result came in at $164.0 million, up 105.0% from the prior year.
  • Change in Intangibles eased to -$461.0 million in Q1 2026 per NVS's latest filing, from $112.0 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $130.0 million in Q1 2023 and troughed at -$929.0 million in Q1 2024.
  • A 5-year average of -$145.8 million and a median of $11.5 million in 2022 frame the typical range for Change in Intangibles.
  • The sharpest annual moves came in 2023 and 2024: Change in Intangibles plunged 14166.67% in 2023, then jumped 1750.0% in 2024.
  • Over 5 years, Change in Intangibles stood at -$192.0 million in 2022, then jumped by 101.04% to $2.0 million in 2023, then surged by 1750.0% to $37.0 million in 2024, then soared by 202.7% to $112.0 million in 2025, then plunged by 511.61% to -$461.0 million in 2026.
  • According to Business Quant data, Change in Intangibles over the past three periods registered -$461.0 million, $112.0 million, and $52.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 393.11 Mn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -461.00 Mn
Mar 31, 2026 -461.00 Mn
Dec 31, 2025 112.00 Mn
Dec 31, 2025 112.00 Mn
Sep 30, 2025 52.00 Mn
Sep 30, 2025 52.00 Mn
Jun 30, 2025 -227.00 Mn
Jun 30, 2025 -227.00 Mn
Dec 31, 2024 37.00 Mn
Dec 31, 2024 37.00 Mn
Sep 30, 2024 23.00 Mn
Sep 30, 2024 23.00 Mn
Jun 30, 2024 20.00 Mn
Jun 30, 2024 20.00 Mn
Mar 31, 2024 -929.00 Mn
Mar 31, 2024 -929.00 Mn
Dec 31, 2023 2.00 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 -422.00 Mn
Sep 30, 2023 -422.00 Mn